N

Natco Pharma Ltd

PharmaceuticalsSmallcap

About the company

Natco Pharma Limited is a research and development (R&D)-focused pharmaceutical company. The Company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs).

Performance

Stock
Loading Stock value
—

Analyst Ratings and Key Metrics

Based on 11 analysts offering recommendations for Natco Pharma Ltd

46%

Buy

27%

Hold

27%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio10.9244.84
PB Ratio1.685.62
Dividend Yield0.58%0.51%

Understand what these metrics mean. 

Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions